カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のニモツズマブ市場2022年：0.5ML、 1ML、 その他

◆英語タイトル：Global Nimotuzumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8905）◆商品コード：GIR22MY8905
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：97
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ニモツズマブ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニモツズマブの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニモツズマブ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・0.5ML、 1ML、 その他

用途別セグメントは次のように区分されます。
・消化器腫瘍、頭頸部腫瘍、悪性神経膠腫、その他

世界のニモツズマブ市場の主要な市場プレーヤーは以下のとおりです。
・InnoKeys、Roche Diagnostics GmbH、Johnson & Johnson、Amgen、GSK、Jiangsu Hengrui Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニモツズマブ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニモツズマブメーカーの企業概要、2019年～2022年までのニモツズマブの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニモツズマブメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニモツズマブの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニモツズマブの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニモツズマブ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニモツズマブの産業チェーンを掲載しています。
・第13、14、15章では、ニモツズマブの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：InnoKeys、Roche Diagnostics GmbH、Johnson & Johnson、Amgen、GSK、Jiangsu Hengrui Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：0.5ML、 1ML、 その他
・用途別分析2017年-2028年：消化器腫瘍、頭頸部腫瘍、悪性神経膠腫、その他
・ニモツズマブの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニモツズマブのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニモツズマブのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニモツズマブの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニモツズマブの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nimotuzumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nimotuzumab market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Digestive Tumor accounting for % of the Nimotuzumab global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 0.5ML segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nimotuzumab include InnoKeys, Roche Diagnostics GmbH, Johnson & Johnson, Amgen, and GSK, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nimotuzumab market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.5ML
1ML
Other
Market segment by Application can be divided into
Digestive Tumor
Head And Neck Tumor
Malignant Glioma
Other
The key market players for global Nimotuzumab market are listed below:
InnoKeys
Roche Diagnostics GmbH
Johnson & Johnson
Amgen
GSK
Jiangsu Hengrui Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nimotuzumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nimotuzumab, with price, sales, revenue and global market share of Nimotuzumab from 2019 to 2022.
Chapter 3, the Nimotuzumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nimotuzumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nimotuzumab market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nimotuzumab.
Chapter 13, 14, and 15, to describe Nimotuzumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Nimotuzumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nimotuzumab Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 0.5ML
1.2.3 1ML
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nimotuzumab Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Digestive Tumor
1.3.3 Head And Neck Tumor
1.3.4 Malignant Glioma
1.3.5 Other
1.4 Global Nimotuzumab Market Size & Forecast
1.4.1 Global Nimotuzumab Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nimotuzumab Sales in Volume (2017-2028)
1.4.3 Global Nimotuzumab Price (2017-2028)
1.5 Global Nimotuzumab Production Capacity Analysis
1.5.1 Global Nimotuzumab Total Production Capacity (2017-2028)
1.5.2 Global Nimotuzumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nimotuzumab Market Drivers
1.6.2 Nimotuzumab Market Restraints
1.6.3 Nimotuzumab Trends Analysis
2 Manufacturers Profiles
2.1 InnoKeys
2.1.1 InnoKeys Details
2.1.2 InnoKeys Major Business
2.1.3 InnoKeys Nimotuzumab Product and Services
2.1.4 InnoKeys Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche Diagnostics GmbH
2.2.1 Roche Diagnostics GmbH Details
2.2.2 Roche Diagnostics GmbH Major Business
2.2.3 Roche Diagnostics GmbH Nimotuzumab Product and Services
2.2.4 Roche Diagnostics GmbH Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Nimotuzumab Product and Services
2.3.4 Johnson & Johnson Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Nimotuzumab Product and Services
2.4.4 Amgen Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK Nimotuzumab Product and Services
2.5.4 GSK Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu Hengrui Pharmaceutical
2.6.1 Jiangsu Hengrui Pharmaceutical Details
2.6.2 Jiangsu Hengrui Pharmaceutical Major Business
2.6.3 Jiangsu Hengrui Pharmaceutical Nimotuzumab Product and Services
2.6.4 Jiangsu Hengrui Pharmaceutical Nimotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nimotuzumab Breakdown Data by Manufacturer
3.1 Global Nimotuzumab Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nimotuzumab Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nimotuzumab
3.4 Market Concentration Rate
3.4.1 Top 3 Nimotuzumab Manufacturer Market Share in 2021
3.4.2 Top 6 Nimotuzumab Manufacturer Market Share in 2021
3.5 Global Nimotuzumab Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nimotuzumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nimotuzumab Market Size by Region
4.1.1 Global Nimotuzumab Sales in Volume by Region (2017-2028)
4.1.2 Global Nimotuzumab Revenue by Region (2017-2028)
4.2 North America Nimotuzumab Revenue (2017-2028)
4.3 Europe Nimotuzumab Revenue (2017-2028)
4.4 Asia-Pacific Nimotuzumab Revenue (2017-2028)
4.5 South America Nimotuzumab Revenue (2017-2028)
4.6 Middle East and Africa Nimotuzumab Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nimotuzumab Sales in Volume by Type (2017-2028)
5.2 Global Nimotuzumab Revenue by Type (2017-2028)
5.3 Global Nimotuzumab Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nimotuzumab Sales in Volume by Application (2017-2028)
6.2 Global Nimotuzumab Revenue by Application (2017-2028)
6.3 Global Nimotuzumab Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nimotuzumab Sales by Type (2017-2028)
7.2 North America Nimotuzumab Sales by Application (2017-2028)
7.3 North America Nimotuzumab Market Size by Country
7.3.1 North America Nimotuzumab Sales in Volume by Country (2017-2028)
7.3.2 North America Nimotuzumab Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nimotuzumab Sales by Type (2017-2028)
8.2 Europe Nimotuzumab Sales by Application (2017-2028)
8.3 Europe Nimotuzumab Market Size by Country
8.3.1 Europe Nimotuzumab Sales in Volume by Country (2017-2028)
8.3.2 Europe Nimotuzumab Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nimotuzumab Sales by Type (2017-2028)
9.2 Asia-Pacific Nimotuzumab Sales by Application (2017-2028)
9.3 Asia-Pacific Nimotuzumab Market Size by Region
9.3.1 Asia-Pacific Nimotuzumab Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nimotuzumab Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nimotuzumab Sales by Type (2017-2028)
10.2 South America Nimotuzumab Sales by Application (2017-2028)
10.3 South America Nimotuzumab Market Size by Country
10.3.1 South America Nimotuzumab Sales in Volume by Country (2017-2028)
10.3.2 South America Nimotuzumab Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nimotuzumab Sales by Type (2017-2028)
11.2 Middle East & Africa Nimotuzumab Sales by Application (2017-2028)
11.3 Middle East & Africa Nimotuzumab Market Size by Country
11.3.1 Middle East & Africa Nimotuzumab Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nimotuzumab Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nimotuzumab and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nimotuzumab
12.3 Nimotuzumab Production Process
12.4 Nimotuzumab Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nimotuzumab Typical Distributors
13.3 Nimotuzumab Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nimotuzumab Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nimotuzumab Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. InnoKeys Basic Information, Manufacturing Base and Competitors
Table 4. InnoKeys Major Business
Table 5. InnoKeys Nimotuzumab Product and Services
Table 6. InnoKeys Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 8. Roche Diagnostics GmbH Major Business
Table 9. Roche Diagnostics GmbH Nimotuzumab Product and Services
Table 10. Roche Diagnostics GmbH Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Nimotuzumab Product and Services
Table 14. Johnson & Johnson Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amgen Basic Information, Manufacturing Base and Competitors
Table 16. Amgen Major Business
Table 17. Amgen Nimotuzumab Product and Services
Table 18. Amgen Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Major Business
Table 21. GSK Nimotuzumab Product and Services
Table 22. GSK Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Hengrui Pharmaceutical Major Business
Table 25. Jiangsu Hengrui Pharmaceutical Nimotuzumab Product and Services
Table 26. Jiangsu Hengrui Pharmaceutical Nimotuzumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Nimotuzumab Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Nimotuzumab Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Nimotuzumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Nimotuzumab Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Nimotuzumab Production Site of Key Manufacturer
Table 32. Nimotuzumab New Entrant and Capacity Expansion Plans
Table 33. Nimotuzumab Mergers & Acquisitions in the Past Five Years
Table 34. Global Nimotuzumab Sales by Region (2017-2022) & (K Units)
Table 35. Global Nimotuzumab Sales by Region (2023-2028) & (K Units)
Table 36. Global Nimotuzumab Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Nimotuzumab Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 39. Global Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 40. Global Nimotuzumab Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Nimotuzumab Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Nimotuzumab Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Nimotuzumab Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 45. Global Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 46. Global Nimotuzumab Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Nimotuzumab Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Nimotuzumab Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Nimotuzumab Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Nimotuzumab Sales by Country (2017-2022) & (K Units)
Table 51. North America Nimotuzumab Sales by Country (2023-2028) & (K Units)
Table 52. North America Nimotuzumab Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Nimotuzumab Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 55. North America Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 56. North America Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 57. North America Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 58. Europe Nimotuzumab Sales by Country (2017-2022) & (K Units)
Table 59. Europe Nimotuzumab Sales by Country (2023-2028) & (K Units)
Table 60. Europe Nimotuzumab Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Nimotuzumab Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 63. Europe Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 64. Europe Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 65. Europe Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Nimotuzumab Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Nimotuzumab Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Nimotuzumab Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Nimotuzumab Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 74. South America Nimotuzumab Sales by Country (2017-2022) & (K Units)
Table 75. South America Nimotuzumab Sales by Country (2023-2028) & (K Units)
Table 76. South America Nimotuzumab Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Nimotuzumab Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 79. South America Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 80. South America Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 81. South America Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Nimotuzumab Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Nimotuzumab Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Nimotuzumab Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Nimotuzumab Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Nimotuzumab Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Nimotuzumab Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Nimotuzumab Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Nimotuzumab Sales by Application (2023-2028) & (K Units)
Table 90. Nimotuzumab Raw Material
Table 91. Key Manufacturers of Nimotuzumab Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Nimotuzumab Typical Distributors
Table 95. Nimotuzumab Typical Customers
List of Figures
Figure 1. Nimotuzumab Picture
Figure 2. Global Nimotuzumab Revenue Market Share by Type in 2021
Figure 3. 0.5ML
Figure 4. 1ML
Figure 5. Other
Figure 6. Global Nimotuzumab Revenue Market Share by Application in 2021
Figure 7. Digestive Tumor
Figure 8. Head And Neck Tumor
Figure 9. Malignant Glioma
Figure 10. Other
Figure 11. Global Nimotuzumab Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Nimotuzumab Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Nimotuzumab Sales (2017-2028) & (K Units)
Figure 14. Global Nimotuzumab Price (2017-2028) & (US$/Unit)
Figure 15. Global Nimotuzumab Production Capacity (2017-2028) & (K Units)
Figure 16. Global Nimotuzumab Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Nimotuzumab Market Drivers
Figure 18. Nimotuzumab Market Restraints
Figure 19. Nimotuzumab Market Trends
Figure 20. Global Nimotuzumab Sales Market Share by Manufacturer in 2021
Figure 21. Global Nimotuzumab Revenue Market Share by Manufacturer in 2021
Figure 22. Nimotuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Nimotuzumab Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Nimotuzumab Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Nimotuzumab Sales Market Share by Region (2017-2028)
Figure 26. Global Nimotuzumab Revenue Market Share by Region (2017-2028)
Figure 27. North America Nimotuzumab Revenue (2017-2028) & (USD Million)
Figure 28. Europe Nimotuzumab Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Nimotuzumab Revenue (2017-2028) & (USD Million)
Figure 30. South America Nimotuzumab Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Nimotuzumab Revenue (2017-2028) & (USD Million)
Figure 32. Global Nimotuzumab Sales Market Share by Type (2017-2028)
Figure 33. Global Nimotuzumab Revenue Market Share by Type (2017-2028)
Figure 34. Global Nimotuzumab Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 36. Global Nimotuzumab Revenue Market Share by Application (2017-2028)
Figure 37. Global Nimotuzumab Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Nimotuzumab Sales Market Share by Type (2017-2028)
Figure 39. North America Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 40. North America Nimotuzumab Sales Market Share by Country (2017-2028)
Figure 41. North America Nimotuzumab Revenue Market Share by Country (2017-2028)
Figure 42. United States Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Nimotuzumab Sales Market Share by Type (2017-2028)
Figure 46. Europe Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 47. Europe Nimotuzumab Sales Market Share by Country (2017-2028)
Figure 48. Europe Nimotuzumab Revenue Market Share by Country (2017-2028)
Figure 49. Germany Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Nimotuzumab Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Nimotuzumab Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Nimotuzumab Revenue Market Share by Region (2017-2028)
Figure 58. China Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Nimotuzumab Sales Market Share by Type (2017-2028)
Figure 65. South America Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 66. South America Nimotuzumab Sales Market Share by Country (2017-2028)
Figure 67. South America Nimotuzumab Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Nimotuzumab Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Nimotuzumab Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Nimotuzumab Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Nimotuzumab Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Nimotuzumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Nimotuzumab in 2021
Figure 79. Manufacturing Process Analysis of Nimotuzumab
Figure 80. Nimotuzumab Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のニモツズマブ市場2022年：0.5ML、 1ML、 その他(Global Nimotuzumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のパルスオキシメトリセンサー市場2022年：再利用可能パルスオキシメトリセンサー、再利用不可能パルスオキシメトリセンサー
  • 世界の流動性止血鉗子市場2022年：豚ゼラチン、牛ゼラチン
  • 世界の眼窩周囲インプラント市場2022年：CHA、 MCI
  • 世界の肋骨骨折修復システム市場2022年：Uプレート肋骨骨折修復システム、前部プレート肋骨骨折修復システム
  • 世界の内視鏡縫合装置市場2022年：使い捨て縫合装置、多目的縫合装置